Vorsprung durch Technik.” That bit of Teutonic marketing translates from German to “progress through technology,” and since ...

Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.

Revenue: $530 million for Q4 2024, down 1% year-over-year, flat organically. GAAP Operating Margin: Negative 6.9% due to $93 million in noncash goodwill and intangible impairment charges.

Net Sales (Q4 2024): $541.6 million, a decrease of 8% from $589.1 million in Q4 2023. Gross Margin (Q4 2024): 32.5%, down from 34.5% in Q4 2023. Operating Expenses (Q4 2024): $86.5 million ...

Roth Capital also issued estimates for MAG Silver’s Q1 2025 earnings at $0.25 EPS, Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.26 EPS, Q4 2025 earnings at $0.23 EPS and FY2025 earnings ...

MAG Silver Corp. (TSE:MAG – Free Report) (NYSEAMERICAN:MAG) – Equities research analysts at Cormark issued their Q4 2024 earnings estimates for MAG Silver in a research note issued to ...

Q4 2024 net income was $1.3 million ($0.40 per share), up $607 thousand over Q3 2024, and up $1.2 million from Q4 2023. FY 2024 net income was $3.3 million ($0.98 per share) compared to $3.2 ...

Welcome to the Q4 and Full Year 2024 Conference Call for Investors and Analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual forward ...

In addition, you can check the fund’s top 5 holdings to find out its best picks for 2024. A copy of Summers Value Partners’ Q4 2024 investor letter can be downloaded here. Artificial ...

ArcBest Corp. posted declines in profit and revenue for the fourth quarter of 2024, according to a Jan ... on revenue of $4.43 billion in 2023. During Q4, asset-based segment revenue decreased ...